ALK-Abello AS - Company Profile
Powered by
All the data and insights you need on ALK-Abello AS in one report.
- Save hours of research time and resources with
our up-to-date ALK-Abello AS Strategy Report
- Understand ALK-Abello AS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
ALK-Abello AS (ALK), a subsidiary of The Lundbeck Foundation, develops products with a focus on diagnosis, prevention, and treatment of allergy. The company harnesses its established market position, improved operational performance, and focus on R&D activities to achieve growth. However, product recall issue could be a cause for concern. The growing market for Allergic Rhinitis treatments, strong product pipeline, strategic contracts and agreements could augment the company’s revenue. Nevertheless, intense competitive pressure, dependence on third parties, and stringent regulations could affect its business.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer